Vaccines

21 Dec 2009 Medicago reports positive Phase I results for its avian flu pandemic vaccine
18 Dec 2009 Novartis meningococcal vaccine Menveo® recommended for approval in the European Union for prevention of disease in adolescents and adults
16 Dec 2009 Intercell provides update on ongoing Phase II vaccine studies
16 Dec 2009 Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections
15 Dec 2009 Sanofi Pasteur expands study of vaccine against Clostridium difficile into the U.S.
14 Dec 2009 Pfizer Receives European Authorization For Prevenar 13* For The Prevention Of Pneumococcal Disease In Infants And Young Children
14 Dec 2009 Generex Presents Encouraging Interim Results of Phase II Breast Cancer Study
11 Dec 2009 GSK and Intercell form strategic alliance to develop and commercialise innovative needle-free patch-based vaccines
10 Dec 2009 Merck KGaA Starts Stimuvax Phase III Study INSPIRE in Asian Patients with Advanced NSCLC
09 Dec 2009 Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America
09 Dec 2009 Nabi Biopharmaceuticals to Receive $5 Million Milestone Payment From GlaxoSmithKline Biologicals
09 Dec 2009 Immunovaccine Receives Clearance From FDA to Proceed With Phase 1 Clinical Trial for Its Therapeutic Cancer Vaccine
08 Dec 2009 Neovacs Initiates a Phase II Clinical Trial of TNF Kinoid in Rheumatoid Arthritis Patients Failing TNF Monoclonal Antibody Therapy
07 Dec 2009 Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study
02 Dec 2009 NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico
01 Dec 2009 GSK Update: GSK’s Arepanrix™ H1N1 pandemic vaccine prequalified by the World Health Organization
30 Nov 2009 NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults
27 Nov 2009 STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe
27 Nov 2009 The ChronVac-C study has been successfully completed with good safety and favorable clinical data
27 Nov 2009 FDA Approves Agriflu Seasonal Influenza Vaccine
26 Nov 2009 Planet Biopharmaceuticals Announces Annual Meeting and Results of Clinical Trials
23 Nov 2009 Vical Completes Final Patient Follow-Up in TransVax(TM) CMV Vaccine Phase 2 Trial
20 Nov 2009 Inovio Biomedical Universal Flu Vaccines Demonstrate Broadly Protective Immune Responses Against Multiple Seasonal & Pandemic Influenza Viruses in Pre-Clinical Studies
20 Nov 2009 Circassia Announces Successful Results From Phase II Clinical Study of ToleroMune(R) Cat Allergy Therapy
20 Nov 2009 European CHMP Formally Adopts Negative Opinion on Oncophage

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top